A. S. Allal, P. Dulguerov, M. Allaoua, C. A. Haenggeli, A. El-ghazi-el et al., -Glucose in Predicting Outcome in Head and Neck Carcinomas Treated by Radiotherapy With or Without Chemotherapy, Journal of Clinical Oncology, vol.20, issue.5, pp.1398-1404, 2002.
DOI : 10.1200/JCO.2002.20.5.1398
URL : https://hal.archives-ouvertes.fr/hal-00675599

I. Apostolova, I. G. Steffen, F. Wedel, A. Lougovski, S. Marnitz et al., Asphericity of pretherapeutic tumour FDG uptake provides independent prognostic value in head-and-neck cancer, European Radiology, vol.52, issue.9, pp.2077-2087, 2014.
DOI : 10.1016/j.ijrobp.2003.12.039

H. Ashamalla, M. Mattes, A. Guirguis, A. Zaidi, B. Mokhtar et al., The Anatomical Biological Value on Pretreatment (18)F-fluorodeoxyglucose Positron Emission Tomography Computed Tomography Predicts Response and Survival in Locally Advanced Head and Neck Cancer, World J Nucl Med, vol.13, issue.2, pp.102-107, 2014.

R. Boellaard, R. Delgado-bolton, W. J. Oyen, F. Giammarile, K. Tatsch et al., FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0, FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0, pp.328-354, 2015.
DOI : 10.1097/MNM.0b013e3282eff2d5
URL : https://link.springer.com/content/pdf/10.1007%2Fs00259-014-2961-x.pdf

R. Boellaard, N. C. Krak, O. S. Hoekstra, and A. A. Lammertsma, Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study, J Nucl Med, vol.45, issue.9, pp.1519-1527, 2004.

E. Brun, E. Kjellen, J. Tennvall, T. Ohlsson, A. Sandell et al., FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma, Head & Neck, vol.39, issue.11, pp.127-135, 2002.
DOI : 10.1080/028418600430770

J. Cacicedo, A. Navarro, D. Hoyo, O. Gomez-iturriaga, A. Alongi et al., Role of fluorine-18 fluorodeoxyglucose PET, CT in head and neck oncology: the point of view of the radiation oncologist, 2016.

P. Castaldi, V. Rufini, F. Bussu, F. Micciche, N. Dinapoli et al., Can ???early??? and ???late??? 18F-FDG PET???CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?, Radiotherapy and Oncology, vol.103, issue.1, pp.63-68, 2012.
DOI : 10.1016/j.radonc.2012.03.001

E. Chajon, C. Lafond, G. Louvel, J. Castelli, D. Williaume et al., Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control, Radiation Oncology, vol.8, issue.1, p.132, 2013.
DOI : 10.1016/j.semradonc.2008.09.008
URL : https://hal.archives-ouvertes.fr/inserm-00833043

K. P. Chang, N. M. Tsang, C. T. Liao, C. L. Hsu, M. J. Chung et al., Prognostic Significance of 18F-FDG PET Parameters and Plasma Epstein-Barr Virus DNA Load in Patients with Nasopharyngeal Carcinoma, Journal of Nuclear Medicine, vol.53, issue.1, pp.21-28, 2012.
DOI : 10.2967/jnumed.111.090696

S. W. Chen, T. C. Hsieh, K. Y. Yen, S. N. Yang, Y. C. Wang et al., Interim FDGPET/CT for predicting the outcome in patients with head and neck cancer, The Laryngoscope, vol.59, issue.12, pp.2732-2738, 2014.
DOI : 10.1016/j.ijrobp.2003.12.024

N. M. Cheng, Y. H. Fang, J. T. Chang, C. G. Huang, D. L. Tsan et al., Textural Features of Pretreatment 18F-FDG PET/CT Images: Prognostic Significance in Patients with Advanced T-Stage Oropharyngeal Squamous Cell Carcinoma, Journal of Nuclear Medicine, vol.54, issue.10, pp.1703-1709, 2013.
DOI : 10.2967/jnumed.112.119289

N. M. Cheng, Y. H. Fang, L. Y. Lee, J. T. Chang, D. L. Tsan et al., Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.41, issue.3, pp.419-428, 2015.
DOI : 10.1007/s00259-013-2651-0

A. Depeursinge, A. Foncubierta-rodriguez, D. Van-de-ville, and H. Muller, Three-dimensional solid texture analysis in biomedical imaging: Review and opportunities, Medical Image Analysis, vol.18, issue.1, pp.176-196, 2014.
DOI : 10.1016/j.media.2013.10.005
URL : https://infoscience.epfl.ch/record/196101/files/depeursinge1401.pdf

S. B. Edge and C. C. Compton, The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM, Annals of Surgical Oncology, vol.17, issue.6, pp.1471-1474, 2010.
DOI : 10.1245/s10434-010-0985-4

A. Farrag, G. Ceulemans, M. Voordeckers, H. Everaert, and G. Storme, Can 18F-FDG-PET response during radiotherapy be used as a predictive factor for the outcome of head and neck cancer patients? Nuclear medicine communications, pp.31-495, 2010.

J. W. Fletcher, B. Djulbegovic, H. P. Soares, B. A. Siegel, V. J. Lowe et al., Recommendations on the Use of 18F-FDG PET in Oncology, Journal of Nuclear Medicine, vol.49, issue.3, pp.480-508, 2008.
DOI : 10.2967/jnumed.107.047787

S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. Silverman, R. E. Coleman et al., A tabulated summary of the FDG PET literature, J Nucl Med, vol.42, issue.5, pp.1-93, 2001.

B. Ganeshan, K. A. Miles, R. C. Young, and C. R. Chatwin, Three-Dimensional Selective-Scale Texture Analysis of Computed Tomography Pulmonary Angiograms, Investigative Radiology, vol.43, issue.6, pp.382-394, 2008.
DOI : 10.1097/RLI.0b013e3181690091

K. M. Greven, D. W. Williams, W. F. Mcguirt, . Sr, B. A. Harkness et al., Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer, Head & Neck, vol.36, issue.11, pp.942-946, 2001.
DOI : 10.1148/radiology.212.3.r99se26799

R. M. Haralick, K. Shanmugam, and I. Dinstein, Textural Features for Image Classification, IEEE Transactions on Systems, Man, and Cybernetics, vol.3, issue.6, pp.610-621, 1973.
DOI : 10.1109/TSMC.1973.4309314
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.434.6

M. Hentschel, S. Appold, A. Schreiber, N. Abolmaali, A. Abramyuk et al., Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.25, issue.7, pp.1203-1211, 2011.
DOI : 10.1148/rg.254045136

K. A. Higgins, J. K. Hoang, M. C. Roach, J. Chino, D. S. Yoo et al., Analysis of Pretreatment FDG-PET SUV Parameters in Head-and-Neck Cancer: Tumor SUVmean Has Superior Prognostic Value, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.2, pp.548-553, 2012.
DOI : 10.1016/j.ijrobp.2010.11.050

F. Hofheinz, A. Lougovski, K. Zophel, M. Hentschel, I. G. Steffen et al., Increased evidence for the prognostic value of primary tumor asphericity in pretherapeutic FDG PET for risk stratification in patients with head and neck cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.37, issue.1, pp.429-437, 2015.
DOI : 10.1007/s00259-009-1297-4

C. Horiuchi, T. Taguchi, T. Yoshida, G. Nishimura, M. Kawakami et al., Early assessment of clinical response to concurrent chemoradiotherapy in head and neck carcinoma using fluoro-2-deoxy-d-glucose positron emission tomography, Auris Nasus Larynx, vol.35, issue.1, pp.103-108, 2008.
DOI : 10.1016/j.anl.2007.05.003

H. Hoshikawa, T. Kishino, Y. Nishiyama, Y. Yamamoto, M. Yonezaki et al., Early prediction of local control in head and neck cancer after chemoradiotherapy by FDG-PET. Nuclear medicine communications, pp.32-684, 2011.

H. Hoshikawa, T. Mitani, Y. Nishiyama, Y. Yamamoto, M. Ohkawa et al., Evaluation of the therapeutic effects and recurrence for head and neck cancer after chemoradiotherapy by FDG-PET, Auris Nasus Larynx, vol.36, issue.2, pp.192-198, 2009.
DOI : 10.1016/j.anl.2008.05.009

K. Ito, K. Shimoji, Y. Miyata, K. Kamiya, R. Minamimoto et al., Prognostic value of post-treatment (18)F-FDG PET/CT for advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy, Chin J Cancer Res, vol.26, issue.1, pp.30-37, 2014.

C. H. Kao, S. C. Lin, T. C. Hsieh, K. Y. Yen, S. N. Yang et al., Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy, European Journal of Nuclear Medicine and Molecular Imaging, vol.39, issue.8, pp.1297-1305, 2012.
DOI : 10.1080/00313020701230823

J. W. Keyes and . Jr, SUV: standard uptake or silly useless value?, J Nucl Med, vol.36, issue.10, pp.1836-1839, 1995.

R. Kim, C. Y. Ock, B. Keam, T. M. Kim, J. H. Kim et al., Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study, BMC Cancer, vol.26, issue.10, p.116, 2016.
DOI : 10.1002/hed.20080

Y. Kitagawa, K. Sano, S. Nishizawa, M. Nakamura, T. Ogasawara et al., FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.30, issue.1, pp.63-71, 2003.
DOI : 10.1007/s00259-002-0978-z

P. A. Kyzas, E. Evangelou, D. Denaxa-kyza, and J. P. Ioannidis, 18F-Fluorodeoxyglucose Positron Emission Tomography to Evaluate Cervical Node Metastases in Patients With Head and Neck Squamous Cell Carcinoma: A Meta-analysis, JNCI: Journal of the National Cancer Institute, vol.100, issue.10, pp.712-720, 2008.
DOI : 10.1093/jnci/djn125

T. H. La, E. J. Filion, B. B. Turnbull, J. N. Chu, P. Lee et al., Metabolic Tumor Volume Predicts for Recurrence and Death in Head-and-Neck Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.74, issue.5, pp.1335-1341, 2009.
DOI : 10.1016/j.ijrobp.2008.10.060
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752334

P. Lee, D. K. Weerasuriya, P. W. Lavori, A. Quon, W. Hara et al., Metabolic Tumor Burden Predicts for Disease Progression and Death in Lung Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.69, issue.2, pp.328-333, 2007.
DOI : 10.1016/j.ijrobp.2007.04.036

Y. C. Lin, S. W. Chen, T. C. Hsieh, K. Y. Yen, S. N. Yang et al., Risk Stratification of Metastatic Neck Nodes by CT and PET in Patients with Head and Neck Cancer Receiving Definitive Radiotherapy, Journal of Nuclear Medicine, vol.56, issue.2, pp.183-189, 2015.
DOI : 10.2967/jnumed.114.148023

M. Lonneux, M. Hamoir, H. Reychler, P. Maingon, C. Duvillard et al., F]Fluorodeoxyglucose Improves Staging and Patient Management in Patients With Head and Neck Squamous Cell Carcinoma: A Multicenter Prospective Study, Journal of Clinical Oncology, vol.28, issue.7, pp.1190-1195, 2010.
DOI : 10.1200/JCO.2009.24.6298

M. Machtay, M. Natwa, J. Andrel, T. Hyslop, P. R. Anne et al., Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer, Head & Neck, vol.21, issue.2, pp.195-201, 2009.
DOI : 10.1016/j.ejso.2007.01.002

M. Matoba, H. Tuji, Y. Shimode, T. Kondo, K. Oota et al., Lesion regression rate based on RECIST: prediction of treatment outcome in patients with head and neck cancer treated with chemoradiotherapy compared with FDG PET-CT, Journal of Radiation Research, vol.56, issue.3, pp.553-560, 2015.
DOI : 10.1093/jrr/rru123

M. Min, P. Lin, M. Lee, I. H. Shon, M. Lin et al., 18F-FDG PET-CT performed before and during radiation therapy of head and neck squamous cell carcinoma: Are they independent or complementary to each other? Journal of medical imaging and radiation oncology, 2016.

M. Min, P. Lin, M. T. Lee, I. H. Shon, M. Lin et al., Prognostic role of metabolic parameters of 18F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma, European Journal of Nuclear Medicine and Molecular Imaging, vol.365, issue.13, pp.1984-1994, 2015.
DOI : 10.1016/S0140-6736(05)66698-6

B. J. Moeller, V. Rana, B. A. Cannon, M. D. Williams, E. M. Sturgis et al., Prospective Imaging Assessment of Mortality Risk After Head-and-Neck Radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.3, pp.667-674, 2010.
DOI : 10.1016/j.ijrobp.2009.08.063

J. D. Murphy, T. H. La, K. Chu, A. Quon, N. J. Fischbein et al., Postradiation Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.80, issue.2, pp.514-521, 2011.
DOI : 10.1016/j.ijrobp.2010.01.057
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962876

C. Nahmias and L. M. Wahl, Reproducibility of Standardized Uptake Value Measurements Determined by 18F-FDG PET in Malignant Tumors, Journal of Nuclear Medicine, vol.49, issue.11, pp.1804-1808, 2008.
DOI : 10.2967/jnumed.108.054239

Y. Nakamoto, K. R. Zasadny, H. Minn, and R. L. Wahl, Reproducibility of Common Semi-quantitative Parameters for Evaluating Lung Cancer Glucose Metabolism with Positron Emission Tomography using 2-Deoxy-2-[18F]Fluoro-D-Glucose, Molecular Imaging & Biology, vol.4, issue.2, pp.171-178, 2002.
DOI : 10.1016/S1536-1632(01)00004-X

D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, Global Cancer Statistics, 2002, Global cancer statistics, pp.74-108, 2002.
DOI : 10.3322/canjclin.55.2.74

J. P. Pignon, J. Bourhis, C. Domenge, and L. Designe, Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta analysis of chemotherapy on head and neck cancer, Cancer/Radioth??rapie, vol.5, issue.2, pp.949-955, 2000.
DOI : 10.1016/S1278-3218(00)00073-1

J. H. Rasmussen, I. R. Vogelius, B. M. Fischer, J. Friborg, M. C. Aznar et al., Prognostic value of 18F-fludeoxyglucose uptake in 287 patients with head and neck squamous cell carcinoma, Head & Neck, vol.72, issue.1, pp.1274-1281, 2015.
DOI : 10.1158/0008-5472.CAN-11-3943

P. B. Romesser, R. Lim, D. E. Spratt, J. Setton, N. Riaz et al., The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [18F] fluorodeoxyglucose positron emission tomography scan, Oral Oncology, vol.50, issue.9, pp.802-808, 2014.
DOI : 10.1016/j.oraloncology.2014.06.018

L. Rudmik, H. Y. Lau, T. W. Matthews, J. D. Bosch, R. Kloiber et al., Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: A prospective clinical trial, Head & Neck, vol.108, issue.7, pp.935-940, 2011.
DOI : 10.1097/00005537-199811000-00004

B. Sanghera, W. L. Wong, M. A. Lodge, S. Hain, D. Stott et al., Potential novel application of dual time point SUV measurements as a predictor of survival in head and neck cancer, Nuclear Medicine Communications, vol.26, issue.10, pp.861-867, 2005.
DOI : 10.1097/00006231-200510000-00003

D. A. Schinagl, P. N. Span, W. J. Oyen, and J. H. Kaanders, Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study, European Journal of Nuclear Medicine and Molecular Imaging, vol.51, issue.8, pp.1449-1458, 2011.
DOI : 10.2967/jnumed.108.061499

D. L. Schwartz, J. Harris, M. Yao, D. I. Rosenthal, A. Opanowski et al., Metabolic Tumor Volume as a Prognostic Imaging-Based Biomarker for Head-and-Neck Cancer: Pilot Results From Radiation Therapy Oncology Group Protocol 0522, International Journal of Radiation Oncology*Biology*Physics, vol.91, issue.4, pp.721-729, 2015.
DOI : 10.1016/j.ijrobp.2014.12.023

J. L. St-guily, I. Borget, A. Vainchtock, V. Remy, and C. Takizawa, Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database, Head & neck oncology 2, p.22, 2010.
DOI : 10.1186/1758-3284-2-22

C. Tang, J. D. Murphy, B. Khong, T. H. La, C. Kong et al., Validation that Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.5, pp.1514-1520, 2012.
DOI : 10.1016/j.ijrobp.2011.10.023
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337958

J. A. Thie, Understanding the standardized uptake value, its methods, and implications for usage, J Nucl Med, vol.45, issue.9, pp.1431-1434, 2004.

R. L. Wahl, H. Jacene, Y. Kasamon, and M. A. Lodge, From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors, Journal of Nuclear Medicine, vol.50, issue.Suppl_1, pp.122-150, 2009.
DOI : 10.2967/jnumed.108.057307

W. L. Wong, L. I. Sonoda, A. Gharpurhy, F. Gollub, D. Wellsted et al., 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Assessment of Occult Primary Head and Neck Cancers ??? An Audit and Review of Published Studies, Clinical Oncology, vol.24, issue.3, pp.190-195, 2012.
DOI : 10.1016/j.clon.2011.11.001

K. Yabuki, O. Shiono, M. Komatsu, D. Sano, G. Nishimura et al., Predictive and Prognostic Value of Metabolic Tumor Volume (MTV) in Patients with Laryngeal Carcinoma Treated by Radiotherapy (RT) / Concurrent Chemoradiotherapy (CCRT), PLOS ONE, vol.92, issue.2, p.117924, 2015.
DOI : 10.1371/journal.pone.0117924.t003

J. Yoo, S. Henderson, and C. Walker-dilks, Evidence-based Guideline Recommendations on the Use of Positron Emission Tomography Imaging in Head and Neck Cancer, Clinical Oncology, vol.25, issue.4, pp.33-66, 2013.
DOI : 10.1016/j.clon.2012.08.007

H. Young, R. Baum, U. Cremerius, K. Herholz, O. Hoekstra et al., Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations, European Journal of Cancer, vol.35, issue.13, pp.1773-1782, 1999.
DOI : 10.1016/S0959-8049(99)00229-4

L. Zhu and N. Wang, 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a diagnostic tool in patients with cervical nodal metastases of unknown primary site: A meta-analysis, Surgical Oncology, vol.22, issue.3, pp.190-194, 2013.
DOI : 10.1016/j.suronc.2013.06.002